Back to funds

JOHNSON & JOHNSON

institutionalUpdated 10 days ago

Managed by Johnson & Johnson • Latest filing Q3 2026

Portfolio value
$761.7M
Q3 2026
Filings
5
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
51.2%
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 5 quarters

Show data table
PeriodPortfolio value
Q3 2025$503.7M
Q4 2025$554.6M
Q1 2026$652.4M
Q2 2026$798.7M
Q3 2026$761.7M

Top holdings

15 positions as of Q3 2026

View filing
P

PROTAGONIST THERAPEUTICS INC

Unchanged
Value
$345.1M
Shares
2.45M
% Port
45.30%
N

NANOBIOTIX

Unchanged
Value
$175.2M
Shares
5.62M
% Port
23.01%
M

MEIRAGTX HLDGS PLC

Unchanged
Value
$73.1M
Shares
6.64M
% Port
9.59%
R

RAPPORT THERAPEUTICS INC

Unchanged
Value
$60M
Shares
1.78M
% Port
7.87%
C

CONTINEUM THERAPEUTICS INC

Unchanged
Value
$26.6M
Shares
1.98M
% Port
3.49%
C

CEREBRAS SYSTEMS INC

+140.1%
Value
$22.9M
Shares
128.6K
% Port
3.00%
X

XENCOR INC

Unchanged
Value
$18.7M
Shares
748.1K
% Port
2.45%
L

LEGEND BIOTECH CORP

Unchanged
Value
$16.2M
Shares
814.6K
% Port
2.13%
F

FATE THERAPEUTICS INC

Unchanged
Value
$8M
Shares
3.38M
% Port
1.05%
C

CVRX INC

Unchanged
Value
$7M
Shares
4.02M
% Port
0.92%
P

PROCEPT BIOROBOTICS CORP

Unchanged
Value
$6.5M
Shares
357.9K
% Port
0.86%
N

NEUMORA THERAPEUTICS INC.

Unchanged
Value
$1.1M
Shares
1.85M
% Port
0.14%
V

VOR BIOPHARMA INC

Unchanged
Value
$1M
Shares
53.7K
% Port
0.13%
L

STANDARD BIOTOOLS INC

Unchanged
Value
$231K
Shares
312.0K
% Port
0.03%
A

ADICET BIO INC

Unchanged
Value
$163K
Shares
22.8K
% Port
0.02%

Explore